Detalles de la búsqueda
1.
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
Cell Immunol
; 356: 104194, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32827943
2.
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis.
Microb Pathog
; 147: 104283, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32485231
3.
An immunoproteomics approach to identify Leishmania infantum proteins to be applied for the diagnosis of visceral leishmaniasis and human immunodeficiency virus co-infection.
Parasitology
; 147(9): 932-939, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32308186
4.
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
Exp Parasitol
; 216: 107941, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32622940
5.
Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans.
Microb Pathog
; 137: 103783, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31600536
6.
Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach.
Parasitology
; 146(11): 1467-1476, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31142384
7.
High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection.
Parasitology
; 146(3): 322-332, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30198459
8.
Leishmania infantum ß-Tubulin Identified by Reverse Engineering Technology through Phage Display Applied as Theranostic Marker for Human Visceral Leishmaniasis.
Int J Mol Sci
; 20(8)2019 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31013713
9.
Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individuals.
Cell Immunol
; 334: 61-69, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30287082
10.
Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
Cell Immunol
; 331: 67-77, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29871740
11.
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis.
Cell Immunol
; 323: 59-69, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29128045
12.
Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.
Int J Mol Sci
; 19(1)2018 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29301342
13.
A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection.
Cell Immunol
; 313: 32-42, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28049560
14.
An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humans.
Cell Immunol
; 318: 42-48, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28602279
15.
Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasis.
Microb Pathog
; 110: 14-22, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28629727
16.
A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.
Parasitol Res
; 115(4): 1649-58, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26782811
17.
Antileishmanial activity and cytotoxicity of Brazilian plants.
Exp Parasitol
; 143: 60-8, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24846006
18.
Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis.
Exp Parasitol
; 132(2): 228-36, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22824583
19.
Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites.
Parasitol Res
; 110(3): 1277-85, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21915627
20.
Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis.
Parasitol Res
; 111(4): 1807-16, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22797606